Clinical Trial Update: A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update assessing the efficacy and safety of Keppra Extended Release Formulation (XR) in epilepsy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra Extended Release Formulation (XR) (levetiracetam ER)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2009-07-28